nintedanib

Poland

Drugs containing this active substance

  • NINTEDANIB ACCORDPHARMA

    This medicine is used in adult patients with a specific type of non-small cell lung cancer (adenocarcinoma), in whom the tumor has started to grow again despite previous treatment with another medicine. It is used in combination with docetaxel.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Accord Healthcare B.V.

  • This medicine is used in adult patients with a specific type of non-small cell lung cancer (adenocarcinoma), where the tumor has started to grow again despite previous treatment with another medicine.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Accord Healthcare B.V.

  • The medicine is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 to 17 years of age). It is also used for the treatment of interstitial lung disease associated with systemic sclerosis in adults, children, and adolescents over 6 years of age.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

  • The medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases (ILD). It is also used in children and adolescents (from 6 years of age) in the case of progressive interstitial lung diseases, and in adults and children with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

  • It is used in the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 to 17 years of age). It is also used in the treatment of interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children from 6 years of age. The medicine helps to reduce further scarring and lung stiffness.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Cyndea Pharma S.L.

  • The medicine is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 to 17 years of age) in the case of progressive lung diseases. It is also used to treat systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children over 6 years of age.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Cyndea Pharma S.L.

  • The medicine is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 years of age) in the case of clinically significant, progressive lung diseases and systemic sclerosis-associated interstitial lung disease.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Adalvo Limited Lek Pharmaceuticals d.d. Pharmadox Healthcare Ltd. Qualimetrix S.A.

  • The medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF) and other chronic lung diseases with interstitial lung disease (ILD). It is also used in children and adolescents (from 6 years of age) in the case of clinically significant, progressive lung diseases, and in people (adults and children from 6 years of age) with systemic sclerosis-associated interstitial lung disease.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Adalvo Limited Lek Pharmaceuticals d.d. Pharmadox Healthcare Ltd. Qualimetrix S.A.

  • The medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic progressive fibrosing interstitial lung diseases, and systemic sclerosis-associated interstitial lung disease.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd.

  • The medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic progressive fibrosing interstitial lung diseases, and systemic sclerosis-associated interstitial lung disease.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd.

  • The medicine is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases in adults, as well as in children and adolescents (from 6 to 17 years of age). It is also used for the treatment of interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children over 6 years of age.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited Qualimetrix S.A. Teva Operations Poland Sp. z o.o.

  • The medicine is used for the treatment of idiopathic pulmonary fibrosis in adults, other chronic fibrosing interstitial lung diseases in adults, as well as in children and adolescents aged 6 to 17 years. It is also used in the treatment of interstitial lung disease associated with systemic sclerosis.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited Qualimetrix S.A. Teva Operations Poland Sp. z o.o.

  • The medicine is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 to 17 years of age). It is also used to treat interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children over 6 years of age.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited Qualimetrix S.A.

  • The medicine is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other progressive fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 to 17 years of age) in the case of clinically significant, progressive interstitial lung diseases. It is also used to treat systemic sclerosis-associated interstitial lung disease in adults, adolescents, and children over 6 years of age.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01EX09

    Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited Qualimetrix S.A.